Cellosaurus logo
expasy logo

Cellosaurus iPS-DF19-9-7T (CVCL_K055)

[Text version]
Cell line name iPS-DF19-9-7T
Synonyms iPS DF19-9-7T; iPS DF19-9-7T-PCBC; DF19-9-7T; DF-19-9-7T; iPS DF 19.7; DF19.7; WAi001-B; PCBC02hsi2011100701; SC11-016
Accession CVCL_K055
Resource Identification Initiative To cite this cell line use: iPS-DF19-9-7T (RRID:CVCL_K055)
Comments Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
From: University of Wisconsin; Madison; USA.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis by RNAseq.
Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
Cell type: Fibroblast of foreskin; CL=CL_1001608.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_4T92 (iPS-DF19-9)
Children:
CVCL_VS02 (WISC011i-inGFPpuro)
Sex of cell Male
Age at sampling <1M
Category Induced pluripotent stem cell
Publications

PubMed=19325077; DOI=10.1126/science.1172482; PMCID=PMC2758053
Yu J.-Y., Hu K.-J., Smuga-Otto K., Tian S.-L., Stewart R., Slukvin I.I., Thomson J.A.
Human induced pluripotent stem cells free of vector and transgene sequences.
Science 324:797-801(2009)

PubMed=21296996; DOI=10.1182/blood-2010-07-298331; PMCID=PMC3083304
Hu K.-J., Yu J.-Y., Suknuntha K., Tian S.-L., Montgomery K.D., Choi K.-D., Stewart R., Thomson J.A., Slukvin I.I.
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
Blood 117:e109-e119(2011)

PubMed=21983960; DOI=10.1038/nmeth.1699; PMCID=PMC3432645
Phanstiel D.H., Brumbaugh J., Wenger C.D., Tian S.-L., Probasco M.D., Bailey D.J., Swaney D.L., Tervo M.A., Bolin J.M., Ruotti V., Stewart R., Thomson J.A., Coon J.J.
Proteomic and phosphoproteomic comparison of human ES and iPS cells.
Nat. Methods 8:821-827(2011)

PubMed=26670276; DOI=10.1038/mtna.2015.42
Kang H., Minder P., Park M.A., Mesquitta W.-T., Torbett B.E., Slukvin I.I.
CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus.
Mol. Ther. Nucleic Acids 4:e268.1-e268.10(2015)

PubMed=27293150; DOI=10.1016/j.stemcr.2016.05.006; PMCID=PMC4944587
Salomonis N., Dexheimer P.J., Omberg L., Schroll R., Bush S., Huo J.S., Schriml L.M., Sui S.H., Keddache M., Mayhew C.N., Shanmukhappa S.K., Wells J.M., Daily K., Hubler S., Wang Y.-L., Zambidis E.T., Margolin A.A., Hide W.A., Hatzopoulos A.K., Malik P., Cancelas J.A., Aronow B.J., Lutzko C.
Integrated genomic analysis of diverse induced pluripotent stem cells from the Progenitor Cell Biology Consortium.
Stem Cell Reports 7:110-125(2016)

Cross-references
Cell line collections (Providers) WiCell; ips-df19-9-7t
WiCell; ips-df19-9-7t-pcbc
Cell line databases/resources hPSCreg; WAi001-B
SKIP; SKIP005451
Biological sample resources BioSamples; SAMEA6260528
ENCODE; ENCBS858DVB
Encyclopedic resources Wikidata; Q54898099
Experimental variables resources EFO; EFO_0007095
Entry history
Entry creation11-Feb-2013
Last entry update10-Sep-2024
Version number23